Gossamer Bio, Inc. (GOSS)

Gossamer Bio, Inc. (GOSS) is a healthcare company (biotechnology) based in the United States. The share price is $10.77, down 1.91% on the day, which values the company at $65.87M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$10.77−1.91% today
Market value
$65.87M
200-week average
$92.0388% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Gossamer Bio, Inc. in more detail

GOSS trades at -0.9× next year's expected earnings, 0.8× sales. It sits 88% below its 200-week average of $92.03.

Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold GOSS, including Zhang Lei (0.1% of the portfolio).

Superinvestors holding GOSS

1 of the investors tracked here report a position in their latest 13F filing.

Gossamer Bio, Inc. (GOSS): questions and answers

What is Gossamer Bio, Inc.'s market cap?

Gossamer Bio, Inc. is valued at $65.87M at a share price of $10.77.

Is GOSS above its 200-week moving average?

No. GOSS is 88.3% below its 200-week average of $92.03. Long-term investors watch that line because strong companies rarely trade below it for long.

Does GOSS pay a dividend?

Gossamer Bio, Inc. does not currently pay a regular dividend.

Which famous investors own GOSS?

In their latest quarterly filings, Zhang Lei (0.1% of the portfolio) hold GOSS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Gossamer Bio, Inc. (GOSS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GOSS

Underlying data: Yahoo Finance; company filings with the SEC.